Copyright
©The Author(s) 2016.
World J Gastroenterol. Jan 21, 2016; 22(3): 1321-1330
Published online Jan 21, 2016. doi: 10.3748/wjg.v22.i3.1321
Published online Jan 21, 2016. doi: 10.3748/wjg.v22.i3.1321
Test | Pro | Con | Sens | Spec |
Serology | Fast, quantification possible | Systemic, not proving intestinal disease; | 98%-100% | 96%-99% |
Antigenemia | Fast, quantification possible | Systemic, not proving intestinal disease labor intensive | 60%-100% | 83%-100% |
Serum PCR | Fast, quantification possible | Systemic, not proving intestinal disease | 65%-100% | 40%-94% |
HE Histology (gold standard?) | Specific, proofs intestinal disease | Slow; low sensitivity | 10%-87% | 92%-100% |
Histology with IHC | Specific, proofs intestinal disease | Slow | 93% | 92%-100% |
Tissue PCR | Quantification possible | Cut-off point unclear, uncertain clinical significance | 65%-100% | 40%-100% |
Stool PCR | Quantification possible | Little experience | 83%% | 93% |
Viral Culture | Very specific | Very slow | 45%-78% | 89%-100% |
Rapid Vial culture | Very specific | Little experience | 68%-100% | 89%-100% |
- Citation: Römkens TE, Bulte GJ, Nissen LH, Drenth JP. Cytomegalovirus in inflammatory bowel disease: A systematic review. World J Gastroenterol 2016; 22(3): 1321-1330
- URL: https://www.wjgnet.com/1007-9327/full/v22/i3/1321.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i3.1321